Bortezomib will enhance the level or influence of flibanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Amplified flibanserin adverse results might come about if coadministered with several weak CYP3A4 inhibitors. To cut back the potential risk of dizziness and lightheadedness, stand up little by little when https://eugened444sdo7.bloggerbags.com/profile